Ibrutinib (I) plus bendamustine and rituximab (BR) in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): a 2-year follow-up of the HELIOS study.


Fraser G., Cramer P., DEMİRKAN F., Silva R. S., Pylypenko H., Grosicki S., ...More

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 3 - 07 June 2016, vol.34 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 34
  • Doi Number: 10.1200/jco.2016.34.15_suppl.7525
  • City: Illinois
  • Country: United States Of America
  • Dokuz Eylül University Affiliated: Yes